GENESIS Pharma signs agreement for 14 European markets

The Greek pharmaceutical biotechnology company GENESIS Pharma signed an agreement with Deciphera Pharmaceuticals for the exclusive distribution of Ripretinib in 14 markets of Central and Eastern Europe.Based on the…

GENESIS Pharma signs agreement for 14 European markets - Η ΝΑΥΤΕΜΠΟΡΙΚΗ

Keywords
Τυχαία Θέματα